Skip to content
March 28, 2024

Equity.Guru

Investment information for the new generation

Search

extended release

Canntab Therapeutics (PILL.C) announced today that it has reached an agreement with 36Eight Technologies (“36Eight”), whereby “36Eight” will list, market, and support all of Canntab’s market-exclusive and patent-protected solid…